SYNACT PHARMA ApS — Credit Rating and Financial Key Figures

SYNACT PHARMA ApS (CVR number: 34459975) is a company from RUDERSDAL. The company recorded a gross profit of -63448.4 kDKK in 2023. The operating profit was -70.9 mDKK, while net earnings were -65.4 mDKK. The profitability of the company measured by Return on Assets (ROA) was -218.8 %, which can be considered poor and Return on Equity (ROE) was -263.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 58.2 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. SYNACT PHARMA ApS's liquidity measured by quick ratio was 2.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.